SCHEMBL9669191

SCHEMBL9669191

O=[C]c1ccc2ccccc2c1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.54
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
TSHR P16473 2/20 0.44
PAX8 Q06710 1/20 0.43
CYP1A2 P05177 2/20 0.41
HPRT1 P00492 1/20 0.41
LMNA P02545 5/20 0.40
NCEH1 Q6PIU2 1/20 0.40
HIF1A Q16665 1/20 0.38
CYP1B1 Q16678 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
TP53 P04637 2/20 0.37
POLB P06746 1/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
ITGB2 P05107 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18245066 0.79 CYP2A6 (0.54) CYP2A6ALDH1A1HSD17B10TDP1TSHR
SCHEMBL11556490 0.79 CYP2A6 (0.54) CYP2A6ALDH1A1HSD17B10TDP1TSHR
SCHEMBL10427612 0.78 ALDH1A1 (0.48) CYP2A6ALDH1A1HSD17B10TDP1TSHR
SCHEMBL3441131 0.77 ALDH1A1 (0.46) CYP2A6ALDH1A1HSD17B10TDP1TSHR
SCHEMBL2231383 0.75 PTPN22 (0.54) CYP2A6ALDH1A1HSD17B10TDP1TSHR
SCHEMBL9669197 0.75 TSHR (0.54) CYP2A6ALDH1A1HSD17B10TDP1TSHR
SCHEMBL8183400 0.75 POLB (0.50) CYP2A6ALDH1A1HSD17B10TDP1TSHR
SCHEMBL103338 0.74
SCHEMBL9004 0.73 CA1 (0.52) CYP2A6ALDH1A1HSD17B10TDP1TSHR
SCHEMBL23854476 0.72 ALDH1A1 (0.41) CYP2A6ALDH1A1HSD17B10TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 US disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed